All In MedTech

Device Trial Radar · NCT07909499

BD Onclarity HPV Assay on the BD COR Instrument: Self-collected Vaginal Swabs Validation

BD Onclarity HPV Assay on the BD COR Instrument: a Performance Analysis Comparing Two Self-collected Vaginal Swabs From Volunteer IU Health Pathology Laboratory Team Members for Laboratory Validation

Last checked: Nov 20, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

40

Planned (sponsor's estimate)

Start

Nov 15, 2026

Primary completion

Dec 15, 2026

Study completion Dec 15, 2026

Sponsor

Lead sponsor
Indiana UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 2, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
Yes
Who can join
Female only, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study is being done to help IU Health validate a new method for HPV testing using self-collected vaginal swab samples. Volunteers will collect two vaginal swabs during a single study visit. The test results from these samples will be compared to results from an already validated collection method to make sure the new testing process performs as expected. The information gathered will be used for laboratory validation and will not be used for medical care or reported back to participants.

Conditions

  • Healthy Subjects
  • HPV

Interventions

  • BD Cor OnClarity Self-CollectionDevice

    Participants will self-collect two vaginal specimens during a single study visit, including one specimen using the currently validated in-office self-collection method and one specimen using the BD Onclarity At-Home Self-Collection Kit. Both specimens will undergo HPV testing using the BD Onclarity HPV Assay on the BD COR System. Results will be compared to evaluate the performance of at-home self-collected specimens and support laboratory validation prior to clinical implementation.

  • BD Onclarity HPV AssayDiagnostic test

    HPV testing of paired self-collected vaginal specimens using the BD Onclarity HPV Assay on the BD COR System to support laboratory validation of at-home self-collection for HPV screening.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical Sensitivity of Self-Collected Vaginal Swabs for Detection of High-Risk HPVTime frame: At specimen collection and completion of laboratory testing (up to 30 days)
  2. Overall Agreement Between Self-Collected Vaginal Swabs and Reference Laboratory HPV ResultsTime frame: At specimen collection and completion of laboratory testing (up to 30 days)
  3. Clinical Specificity of Self-Collected Vaginal Swabs for Detection of High-Risk HPVTime frame: At specimen collection and completion of laboratory testing (up to 30 days)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Indiana University, Department of Pathology

    Indianapolis, Indiana

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.